These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9018647

  • 1. Methotrexate. A single agent for early abortion.
    Schaff EA, Penmetsa U, Eisinger SH, Franks P.
    J Reprod Med; 1997 Jan; 42(1):56-60. PubMed ID: 9018647
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate and misoprostol for early abortion.
    Schaff EA, Eisinger SH, Franks P, Kim SS.
    Fam Med; 1996 Mar; 28(3):198-203. PubMed ID: 8900553
    [Abstract] [Full Text] [Related]

  • 3. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K, Pekhlivanov B, Amaliev I.
    Akush Ginekol (Sofiia); 2005 Mar; 44(3):16-8. PubMed ID: 16028385
    [Abstract] [Full Text] [Related]

  • 4. Abortion induced with methotrexate and misoprostol.
    Wiebe ER.
    CMAJ; 1996 Jan 15; 154(2):165-70. PubMed ID: 8548705
    [Abstract] [Full Text] [Related]

  • 5. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA, Stadalius LS, Eisinger SH, Franks P.
    J Fam Pract; 1997 Apr 15; 44(4):353-60. PubMed ID: 9108832
    [Abstract] [Full Text] [Related]

  • 6. Misoprostol administration in medical abortion. A comparison of three regimens.
    Wiebe ER.
    J Reprod Med; 2001 Feb 15; 46(2):125-9. PubMed ID: 11255811
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
    Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G.
    Contraception; 1996 Jun 15; 53(6):321-7. PubMed ID: 8773418
    [Abstract] [Full Text] [Related]

  • 8. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.
    Wiebe ER, Trouton K.
    Contraception; 2004 Dec 15; 70(6):463-6. PubMed ID: 15541407
    [Abstract] [Full Text] [Related]

  • 9. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R, Rana A, Pradhan N.
    J Obstet Gynaecol Res; 2009 Feb 15; 35(1):78-85. PubMed ID: 19215552
    [Abstract] [Full Text] [Related]

  • 10. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    BJOG; 2005 Aug 15; 112(8):1102-8. PubMed ID: 16045525
    [Abstract] [Full Text] [Related]

  • 11. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K, Fong YF, Dong F.
    BJOG; 2003 Feb 15; 110(2):175-80. PubMed ID: 12618162
    [Abstract] [Full Text] [Related]

  • 12. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J, Chien PF, Thomson MA, Kosseim ML.
    BJOG; 2007 Feb 15; 114(2):207-15. PubMed ID: 17305893
    [Abstract] [Full Text] [Related]

  • 13. Comparing abortion induced with methotrexate and misoprostol to methotrexate alone.
    Wiebe ER.
    Contraception; 1999 Jan 15; 59(1):7-10. PubMed ID: 10342080
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate and misoprostol used alone or in combination for early abortion.
    Ozeren M, Bilekli C, Aydemir V, Bozkaya H.
    Contraception; 1999 Jun 15; 59(6):389-94. PubMed ID: 10518234
    [Abstract] [Full Text] [Related]

  • 15. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T, Winikoff B.
    BJOG; 2007 May 15; 114(5):555-62. PubMed ID: 17439563
    [Abstract] [Full Text] [Related]

  • 16. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N, Kountouris A, Botsis D, Rizos D, Gregoriou O, Detsis G, Creatsas G.
    Eur J Contracept Reprod Health Care; 2005 Dec 15; 10(4):249-54. PubMed ID: 16448952
    [Abstract] [Full Text] [Related]

  • 17. Misoprostol for abortion at 9-12 weeks' gestation in adolescents.
    Carbonell JL, Velazco A, Varela L, Tanda R, Sánchez C, Barambio S, Chami S, Valero F, Aragón S, Marí J.
    Eur J Contracept Reprod Health Care; 2001 Mar 15; 6(1):39-45. PubMed ID: 11334475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH, Han XJ, Wu SY, Xiao DZh, Xiong CL, Wu XR.
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct 15; 116(2):211-6. PubMed ID: 15358467
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    Hum Reprod; 2005 Aug 15; 20(8):2348-54. PubMed ID: 15878927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.